Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3092310 | 0.84 | TK1 (0.48) | TK1 | |
| SCHEMBL11121219 | 0.81 | TK1 (0.46) | TK1 | |
| SCHEMBL2056793 | 0.81 | TK1 (0.52) | TK1 | |
| SCHEMBL2056794 | 0.81 | TK1 (0.52) | TK1 | |
| SCHEMBL21345227 | 0.80 | TK1 (0.54) | TK1 | |
| SCHEMBL3281 | 0.80 | TK1 (0.50) | TK1DHFR | |
| SCHEMBL9416243 | 0.80 | TK1 (0.45) | TK1 | |
| SCHEMBL9392097 | 0.80 | POLB (0.49) | TK1DHFR | |
| SCHEMBL2885 | 0.79 | TK1 (0.50) | TK1DHFR | |
| SCHEMBL7543825 | 0.79 | TK1 (0.46) | TK1DHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4220 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260083840-A1 | METHODS FOR ABLATING MYELOID DERIVED SUPPRESSOR CELLS USING NEO-201 ANTIBODY | PREC BIOLOGICS INC (US) | 2026-03-26 | — | — | US | claimed |
| CN-121570613-A | Functionalized nano-particles loaded with antiviral drugs, collagen-based hydrogel eye drops based on in-situ catalytic oxygen production, and preparation method and application thereof | 四川大学 | 2026-02-27 | — | — | CN | claimed |
| WO-2026043843-A1 | TETRAHYDROPYRIMIDINE (THP) IONIZABLE LIPIDS FOR EFFICIENT MRNA DELIVERY | THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, (US) | 2026-02-26 | — | — | WO | claimed |
| US-20250242040-A1 | ALBUMIN CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF | Suzhou KangDeRui Pharmaceutical, Ltd. (CN) | 2025-07-31 | — | — | US | claimed |
| CN-119403836-A | Methods for eliminating myeloid-derived suppressor cells using NEO-201 antibodies | 精密生物制品股份有限公司 | 2025-02-07 | — | — | CN | claimed |
| EP-4499710-A1 | METHODS FOR ABLATING MYELOID DERIVED SUPPRESSOR CELLS USING NEO-201 ANTIBODY | Precision Biologics, Inc. (US) | 2025-02-05 | — | — | EP | claimed |
| WO-2024264038-A2 | NEUTRALIZING ANTI-SARS-COV-2 ANTIBODIES | THE ROCKEFELLER UNIVERSITY (US) | 2024-12-26 | — | — | WO | claimed |
| WO-2024036313-A9 | ANTI-SARS-COV-2 ANTIBODIES AND METHODS OF USE THEREOF | THE ROCKEFELLER UNIVERSITY (US) | 2024-12-26 | — | — | WO | claimed |
| US-20240408071-A1 | NOVEL COMBINATION OF SEROTONIN RECEPTOR (5-HTR2B) ANTAGONIST AND AN IMMUNOMODULATOR AND CHEMOTHERAPEUTIC DRUGS FOR INHIBITION OF CANCER | NATIONAL CENTRE FOR CELL SCIENCE (IN) | 2024-12-12 | — | — | US | claimed |
| US-20240400714-A1 | METHODS AND COMPOSITIONS FOR TARGETING TREG CELLS | PREC BIOLOGICS INC (US) | 2024-12-05 | — | — | US | claimed |
| EP-0277270-A2 | N-alkylated quaternary nitrogen-containing heterocycles, process for their preparation and their use in pharmaceutical compositions | MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG (DE) | 1988-08-10 | — | — | EP | claimed |
| EP-0262344-A2 | N-alkylated quaternary nitrogen-containing heterocycles, process for their preparation and their use in pharmaceutical compositions | MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG (DE) | 1988-04-06 | — | — | EP | claimed |
| EP-0262343-A2 | N-alkylated quaternary nitrogen-containing heterocycles, process for their preparation and their use in pharmaceutical compositions | MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG (DE) | 1988-04-06 | — | — | EP | claimed |
| EP-0260428-A2 | Cationic surfactants and pharmaceutical compositions containing them | MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG (DE) | 1988-03-23 | — | — | EP | claimed |
| EP-0260429-A2 | N-alkylated quaternary nitrogen-containing heterocycles, process for their preparation and their use in pharmaceutical compositions | MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG (DE) | 1988-03-23 | — | — | EP | claimed |
| EP-0258672-A2 | Cationic surfactants and pharmaceutical compositions containing them | MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG (DE) | 1988-03-09 | — | — | EP | claimed |
| EP-0257400-A2 | Pharmaceutical compositions containing cationic surfactants | MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG (DE) | 1988-03-02 | — | — | EP | claimed |
| EP-0126684-A2 | Drug delivery system utilizing thermosetting gels | MERCK & CO. INC. (US) | 1984-11-28 | — | — | EP | claimed |
| US-4474751-A | SUSTAINED RELEASE USING AN ALKYLENEDIAMINE-MODIFIED ETHYLENE OXIDE-PROPYLENE OXIDE COPOLYMER | MERCK & CO., INC. (US) | 1984-10-02 | — | — | US | claimed |
| US-4302535-A | Assay for mutagenesis in heterozygous diploid human lymphoblasts | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1981-11-24 | — | — | US | claimed |